The report of Global Obesity Treatment Market By Surgery (Adjusting gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy, Biliopancreatic diversion with Duodenal Switch, Endoscopic Procedures), Drugs (Appetite suppressants, Combination drugs, Malabsorption, Satiety drugs), End Use (Clinics, Hospitals, Beauty institutions), and Region (North America, Europe, Middle East & Africa, South America, Asia Pacific) is expected to reach US$ XX Bn. by 2027, at a CAGR of XX % during a forecast period.
The global Obesity Treatment market is expected to register a significant growth rate over 2019-2027 because of mounting obese population. According to the World Health Organization (WHO), over 50% of the worldwide population is obese. Above 1.9 billion adults, 18 years and elder were overweight in 2014. Among these, over 600 Mn was found to be fat. Obesity is related to chronic diseases for example hypertension, diabetes, orthopaedic disorders and cancer. Therefore, the accelerating rate of the obese population is driving the prevalence of the chronic diseases.
Combination drugs segment held the largest market share in 2019 and is projected to grow at the highest CAGR of XX.66% to reach US$ XX Mn by 2027.
Combination drugs segment is expected to continue to hold the largest XX% share in the obesity treatment market. This is attributed to the synergistic effect of combination therapy in weight management and the growing prevalence of obesity.
North American region is expected to account for the largest XX.60% obesity treatment market share by 2027.
North America is expected to continue to hold the largest XX % share in the obesity treatment market thanks to the easy availability of slightly invasive options and high investments in research & innovations; it is likely to remain at the top during 2019-2027.
Key players operating in the Global Obesity Treatment Market are Olympus Corporation, F. Hoffmann-La Roche, Ltd. , Cousin Biotech , VIVUS, Inc. , Allergan , Johnson & Johnson Services, Inc. , Arena Pharmaceuticals, Inc., Orexigen Therapeutics, Inc. , Medtronic , USGI Medical, Inc., Covidien plc , Mediflex Surgical Products, EnteroMedics, Inc., Novo Nordisk A/S.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the Global Obesity Treatment Market. The report encompasses the market by different segments and regions, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics and future opportunities that might exist in the Global Obesity Treatment Market. The driving forces, as well as considerable restraints, have been explained in depth. in addition to this, competitive landscape describing the strategic growth of the competitors has been taken into consideration for enhancing market know-how of our clients and at the same time explain Global Obesity Treatment Market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Obesity Treatment Market.”
https://www.maximizemarketresearch.com/market-report/global-obesity-treatment-market/70599/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908